Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs
NCT ID: NCT05350930
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2022-06-09
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments
NCT06317389
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer
NCT00420563
Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1
NCT06649474
Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors
NCT01970553
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
NCT02728492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
R-CHOP or G-CHOP chemotherapy
Patients with hematological malignancies receiving R-CHOP or G-CHOP chemotherapy
Assessment of patient satisfaction regarding tele-consultation
Questionnaire completed following the teleconsultation, if applicable.
Literacy questionnaire
Questionnaire completed during hospitalization for the first chemotherapy cycle
Collection of socio-demographic characteristics
Questionnaire completed during patient hospitalization for the first chemotherapy cycle
Assessment of patient knowledge on chemotherapy side effects and support medications
Questionnaire completed during patient hospitalization for the first, second and sixth cycle of chemotherapy
Assessment of patient satisfaction on pharmaceutical follow-up
Questionnaire completed during patient hospitalization for the sixth chemotherapy cycle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of patient satisfaction regarding tele-consultation
Questionnaire completed following the teleconsultation, if applicable.
Literacy questionnaire
Questionnaire completed during hospitalization for the first chemotherapy cycle
Collection of socio-demographic characteristics
Questionnaire completed during patient hospitalization for the first chemotherapy cycle
Assessment of patient knowledge on chemotherapy side effects and support medications
Questionnaire completed during patient hospitalization for the first, second and sixth cycle of chemotherapy
Assessment of patient satisfaction on pharmaceutical follow-up
Questionnaire completed during patient hospitalization for the sixth chemotherapy cycle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients living in an institution
* Patients protected by law
* Adults subject to a legal protection measure (curatorship, guardianship) (article L1121-8 of the CSP)
* Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and persons admitted to a health or social establishment (article L1121-6 of the CSP)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Lyon Sud - Hospices Civils de lyon
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0292
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.